A B S T R A C ' A 5-yr old male proband and his sister have had hypertriglyceridemia and hepatosplenomegaly since birth. When studied on a metabolic ward, they demonstrated rapid decreases in serum triglycerides on 3 g fat/day diets. Oral glucose tolerance tests were normal. Postheparin lipolytic activity (PHLA) against chylomicrons was virtually absent in both children whereas the mother and a normolipemic sister had levels approximately 50% normal. However, all four had a normal PHLA against commercial triglyceride emulsion (Intralipid). 
INTRODUCTION
In the rare, familial type I (exogenous, fat-induced, Burger-Griitz) hyperlipoproteinemia, the postabsorptive plasma appears creamy due to light-scattering chylomicrons. The plasma triglycerides are markedly elevated whereas cholesterol is normal or only slightly increased. The disorder is usually present from childhood and lipemia retinalis, eruptive xanthomata, hepatosplenomegaly, pancreatitis, or obscure bouts of abdominal pain accompany this entity (1) . When dietary fat is restricted to 5 g/day, serum triglycerides and clinical signs both improve.
The defect in this disease appears to be a diminished removal of fat particles secondary to a deficiency of lipoprotein lipase, an enzyme facilitating the uptake of chylomicrons by extrahepatic tissues. Adipose tissue extracts from homozygous type I patients show low lipoprotein lipase activity whereas heterozygous carriers may have intermediate tissue levels (2) . Our studies deal with a family demonstrating the usual clinical history and fat-induction characteristics of type I hyperlipoproteinemia who have an abnormal lipoprotein lipase with unusual substrate specificity and kinetics.
METHODS
All subjects avoided alcohol, excessive dietary fat or carbohydrate, tobacco, and medications (except where indicated in Table I ) for 48 h preceding study. Venous blood was collected the morning after an overnight fast into heparinized or EDTA tubes and immediately centrifuged at 4VC, 5 ,000 rpm. Plasma was either refrigerated at 40C or frozen at -200C before analysis. Lipoprotein electrophoresis was performed within 24 h of collection by the method of Lees and Hatch (3) . Plasma triglycerides (4) and cholesterol (5) were determined on the AutoAnalyzer (Technicon Instruments Corp., Tarrytown, N. Y.).
Postheparin enzyme assays were performed on plasma collected 6, 8, 10 , and 12 min after intravenous injection of 0.1 mg/kg aqueous heparin (Eli Lilly and Co., Indianapolis, Ind., 100 U/mg). Lactescent plasmas were centrifuged at 106,000 g for 1 h at 40C to remove chylomicrons that might serve as endogenous substrate or create pipetting errors. This 1 h centrifugation cleared all plasmas of any turbidity. For simplification, equal volumes of each sample were pooled for a given patient and enzyme assays were performed in duplicate on the single pooled specimen. Results obtained in this manner did not differ significantly from those derived from the mean activity of individual specimens taken 6-12 min after the injection of heparin.
Postheparin lipolytic activity (PHLA).' Both Intralipid (Vitrum-Stockholm) and human chylomicrons were used as substrates for the lipoprotein lipase released by heparin. The Intralipid represents an artificial triglyceride emulsion (containing small amounts of phospholipid and monoglyceride) commonly used for the assay of PHLA. The chylomicrons represent the Sf > 400 fraction obtained by ultracentrifugation at plasma density, 40,000 rpm for 60 min in a Spinco model L using a no. 40 fixed angle rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). The source of this substrate was a chylous ascites effusion occurring in a patient with lymphatic obstruction secondary to retroperitoneal carcinoma. The uncentrifuged effusion was stored under sterile conditions at 4°C and served as a reproducible source of chylomicron substrate for periods up to 4 mo. The actual chylomicron concentrate, decanted after ultracentrifugation, showed gross aggregation with rising FFA concentrations after 1 wk of storage under similar conditions and was therefore prepared fresh each day experiments were performed. There was no difference in enzyme activity against these chylomicrons as compared with those obtained from hyperlipemic plasmas, including the proband's own postheparin chylomicrons. The final assay mixtures were as follows: (a) Chylomicrons. 0.3 ml chylomicron suspension (135 mg triglyceride/ml) in 0.9% saline (pH 8.7), 0.3 ml 0.33 M (NH4)2 SO in 20%o fatty acid-poor albumin (Pentex-Bovine fraction V) (pH 8.7), 0.4 ml plasma. Final pH after incubation ranged from 8.50-8.65. (b) Intralipid. 0.25 ml of 10%o Intralipid (pH 8.7), 0.25 ml 0.4 M (NH4)2 S04 in 20%o fatty acid-poor albumin (pH 8.7), and 0.5 ml plasma. The reaction in each assay was linear for 45 min and substrate concentrations were not rate-limiting. The entire incubation mixture was extracted for FFA determination (6) at 0 and 45 min in duplicate.
To test for circulating plasma inhibitors in the patient's plasma or for a missing component that might be supplied by normal plasma, the following experiments were performed (Table III) . Identical PHLA assays with chylomicron substrates were done with the exception of the plasma component. Normal postheparin plasma was mixed with equal volumes of either preheparin plasma, plasma concentrated 10-fold with polyacrylamide gel (Lyphogel, Gelman Instrument Co., Ann Arbor, Mich.), or the d> 1 Abbreviations used in this paper: PHLA, postheparin lipolytic activity; PHMA, postheparin monogyceridase activity. 1 .063 fraction from either normal or patient's preheparin plasma to test for possible missing components necessary for full lipoprotein lipase activity.
Postheparin monoglyceridase activity (PHMA). A chromatographically pure mixture of 1-, 2-monoolein (3 g/100 ml) was added to Krebs-Ringer's phosphate buffer, pH 7.40, containing 10 g/100 ml FFA-poor albumin and 4 g/100 ml taurodeoxycholate and sonicated until clear. The resultant micellar suspension (0.6 ml) served as a substrate for 0.4 ml postheparin plasma. Samples were extracted at 0 and 90 min for FFA determinations. Results are expressed as microequivalents FFA released/milliliter plasma per hour. Preheparin plasma contains from 0.5 to 1.0 ,ueq FFA/ ml per h monoglyceridase activity but was not assayed in all experiments and therefore the PHMA actually represents the sum of pre-and postheparin monoglyceridase activities.
Postheparin phospholipase. Inosthin, (Associated Concentrates, Woodside, N. Y.) a mixture of soybean phosphatides purified with acetone and ethanol, contains primarily phosphatidyl ethanolamine with trace sterol glycosides but no mono-or triglycerides. This was used as a substrate for phospholipase activity in postheparin plasma by a modification of the method described by Vogel and Zieve (7).
10 ml of 0.1 M glycine buffer, pH 9.6, containing 90 mg Inosthin and 47.5 mg sodium deoxycholate, was sonicated until clear. This suspension (0.7 ml) was then mixed with 0.3 ml plasma and incubated at 37°C for 1 h in duplicate. Samples for FFA determination were taken at 0 and 60 min. The reaction was linear for 2 h. Results are expressed as microequivalents FFA/milliliter plasma per hour.
Lipoprotein lipase: reaction products. To examine changes in size and composition of chylomicrons (Se> 400 lipoproteins) after treatment with heparin-released plasma lipoprotein lipase, 6 ml of either normal or patient's postheparin plasma was incubated with 6 ml of chylomicrons suspended in 0.2 M (NH4)2 SO4, 20% FFA-poor albumin, pH 8.7, at 37°C for 4 h. At intervals, portions were removed from each flask and either applied to Whatman 3M chromatographic paper strips for electrophoresis or added to cellulose nitrate ultracentrifuge tubes containing 0.9 g/100 ml saline plus 3 mg/10 ml diethyl p-nitrosophenylphosphate (Paroxon-Calbiochem, San Diego, Calif), an inhibitor of lipoprotein lipase. The latter were then centrifuged at 106,000 g for 60 min to obtain the Sf > 400 fraction. The remaining infranate was resuspended in saline and centrifuged at the same speed for 24 h. The upper 2 ml was considered as containing only the very low density Sf 20-400 lipoprotein fraction. These migrated primarily in the pre-beta position with minor trailing from the origin on standard paper electrophoresis. Both Sr > 400 and 20-400 fractions were extracted for triglyceride and cholesterol determinations. The incubations were performed once each on two separate days using different chylomicron preparations as substrates. The results were in good qualitative agreement and those of one such experiment are illustrated in Fig Buffer and plasma concentrations were constant at all substrate concentrations. One normal subject (no. 4) and the patient (Da. G.) received 0.5 mg/kg heparin IV in- g ; -a o . . -'°'  . . d . . . . . . . . . . 0 . X . . ! . X U i . . . m . 4 X . -' ' ; . . . after a period of fat restriction. In undiluted specimens there is a heavy accumulation of pre-beta species and a pronounced trail from the origin. When the plasma is diluted to 10% the electrophoretic pattern more clearly represents the typical finding in type I disorders. Fig. 3 illustrates the sharp fall in serum triglycerides on a fat-restricted diet in the proband's younger sister after 10 days. She was then given a "normal" diet for 12 days to demonstrate the persistence of pre-beta, very low density lipoproteins. The carbohydrate content of this diet comprised 37% of the total calories. Not shown in the illustration was the continuing absence of PHLA against chylomicrons on this same diet that contained 30% of its total calories as fat. The PHLA measured against an artificial triglyceride emulsion and true chylomicrons are compared in Table II FIGURE 3 The effect of diet on serum triglycerides and cholesterol in the proband's sister, and the healthy sister and mother had approximately one-half the activity of normal subjects. The two unrelated type I patients from different kinships and a type V patient with diabetes and pancreatitis all had very low PHLA with either substrate. Their postheparin plasmas were treated identically with the proband's including removal of plasma chylomicrons before assay.
The in vitro conversion of large Sf > 400 chylomicrons to smaller, very low density species with pre-beta electrophoretic mobility is shown in Fig. 4 . The patient's plasma, which had low PHLA, catalyzed the change of triglyceride-rich, cholesterol-poor Sf > 400 to a relatively cholesterol-rich chylomicron "remnant" (8) and a triglyceride-rich pre-beta particle. In effect, a purely exogenous type I phenotype was artificially converted to a mixed exogenous, endogenous type V (9) pattern as illustrated in the upper right panel.
The reaction kinetics of plasma lipoprotein lipase were examined in four normal subjects and the proband. (16) and will be discussed below. Steiner (17) has studied a 20-yr old alcoholic male, with no clear family history of hyperlipemia, who had features of fatinduced hypertriglyceridemia, normal PHLA with coconut oil emulsion (Ediol), but a deficient activity against natural chylomicrons similar to our subjects. Studies of five diabetic patients with acquired fat-induced hyperlipemia failed to show this substrate specificity (18) and these observations have been extended by patient G. K. (Table II) (14) who first demonstrated these kinetic differences with the coconut oil substrate (Ediol) in three siblings with familial hyperchylomicronemia. Their PHLA however, were markedly deficient against coconut oil triglycerides and there were also differences from normal seen with ionic and detergent inhibitpr properties. This latter phenomenon may reflect an action on the enzyme-substrate complex formation rather than on the enzyme itself (19) (20) . Further studies on the kinetics of PHLA and substrate specificities must be performed on more cases of this disorder to clarify whether these two kindreds with unusual lipoprotein lipase properties are representative of familial hyperchylomicronemia.
An alternate explanation for the above data might be the compensatory increase of another postheparin triglyceridase that is absent or present in only small amounts in normal postheparin plasma. Others (21) (22) (23) have characterized a rat liver lipase showing differing pH and inhibitor properties from adipose tissue lipoprotein lipase. Herbert et al. (16) have recently reported that postheparin plasma from four type I patients hydrolyzed artificial glyceride emulsions but had different inhibition and activation characteristics from normal postheparin plasmas. They speculate that this triglyceridase originates from the liver as suggested from rat experiments and may also be released by heparin into the circulation of normal subjects. These data, would offer an attractive explanation for our studies. Still another possible explanation for the high apparent Km in an assay system that expresses activity as FFA production from triglyceride, is that enzyme activity is influenced by the size of the lipoprotein-triglyceride particles. In vitro conversion of chylomicrons to "remnants" (9) was observed with our patients' postheparin plasma, but not with normal controls. The possibility exists that normally there are two postheparin triglyceridases (24) , one having greater affinity for Sf > 400 and the other for the smaller Sf 20-400 lipoproteins. If our patients had a deficiency only in the latter case then this would be reflected in an abnormally low PHLA as measured against heterogeneous particle size. However, this explanation is less tenable because of our experiments in which the disappearance of substrate was followed (Fig. 4) . The hydrolysis by the patients' postheparin plasma of both particles, Sf > 400 and Sf 20-400 "remnants" was reduced as compared with normal postheparin plasma. This would suggest that the patients' postheparin plasma had a deficiency of both lipases.
The exogenous pre-beta species produced in vitro may represent the same lipoprotein seen on electrophoresis of all undiluted plasmas from these patients (Fig. 2) . The failure to observe this spectrum of lipoprotein density shifts with normal postheparin plasma may merely reflect the increased affinity of normal lipoprotein lipase for chylomicron triglyceride with completion of hydrolysis at a much faster rate. In this regard, Hazzard, Porte, and Bierman (25) have recently demonstrated in vitro production of triglyceride-poor chylomicrons after 16 h incubation of lipemic, postprandial plasma obtained from type II, III, and V patients. In view of these considerations, it seems prudent not to ascribe the pre-beta lipoproteins observed in our patient's fasting plasma as necessarily being of "endogenous" origin.
Heparin releases at least three other enzyme activities into the circulation: monoglyceridase (26, 27) , phospholipase (7), and a nonspecific esterase (26, 27) . We have measured the first two enzymes and found monoglyceridase activity to be normal or low normal in all patients with familial or acquired hyperchylomicronemia. The phospholipase was low but definitely present. Our findings suggest that these are distinct enzymes but do not exclude a mutant lipoprotein lipase with normal affinity for monoolein or phosphatidyl ethanolamine micelles but decreased activity for chylomicron triglyceride. Other workers have previously reported the varying characteristics of the postheparin lipases (7, (27) (28) (29) (31) . Perhaps the simplest explanation for these data is that lipoprotein lipase has activity against each of these glycerides but other separate heparin-released lipases also exist.
